BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 13885077)

  • 1. [Cellular-Koch bacillus interactions. Discovery of non-specific principles capable of augmenting cellular resistance].
    DELAUNAY A
    Vie Med; 1962 Feb; 43():261-8. PubMed ID: 13885077
    [No Abstract]   [Full Text] [Related]  

  • 2. IN VITRO STUDIES ON THE INTERACTIONS BETWEEN MACROPHAGES OF RABBITS AND TUBERCLE BACILLI. II. CELLULAR AND HUMORAL ASPECTS OF ACQUIRED RESISTANCE.
    HSU HS
    Am Rev Respir Dis; 1965 Apr; 91():499-509. PubMed ID: 14263929
    [No Abstract]   [Full Text] [Related]  

  • 3. [Latent allergy disclosed by the full bacillary bodies and antituberculous resistance brought about by the BCG vaccination].
    BRETEY J; NEGRE L
    Bull Acad Natl Med; 1956 Apr 17-24; 140(13-14):224-5. PubMed ID: 13364454
    [No Abstract]   [Full Text] [Related]  

  • 4. The hemagglutination reaction to BCG and vole bacillus vaccinations.
    HAWIRKO RZ
    Can J Microbiol; 1954 Aug; 1(1):79-84. PubMed ID: 14352042
    [No Abstract]   [Full Text] [Related]  

  • 5. VACCINATION AGAINST TUBERCULOSIS WITH KILLED TUBERCLE BACILLI.
    SWEDBERG B
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:67-76. PubMed ID: 14164138
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental tuberculosis in non-vaccinated dogs and in dogs vaccinated with living (BCG) and dead (AIP, VPS and VDS) bacilli].
    SALVIOLI G; DEGLI ESPOSTI A; DINA MA
    Acta Tuberc Scand; 1953; 28(1-2):147-54. PubMed ID: 13079975
    [No Abstract]   [Full Text] [Related]  

  • 7. THE IMMUNE RESPONSE TO ANTIGENS OF THE TUBERCLE BACILLUS IN RELATION TO SPECIFIC ACQUIRED IMMUNITY.
    BOYDEN SV
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:19-26. PubMed ID: 14164133
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fifty years of the history of antituberculosis killed-bacilli vaccination in humans].
    DE TONI G
    Minerva Med; 1953 Jun; 44(45):1503-12. PubMed ID: 13072081
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antituberculosis vaccination in humans: comparison of killed and live bacilli vaccines].
    DE TONI G
    Minerva Med; 1953 Jun; 44(46):1531-40. PubMed ID: 13072086
    [No Abstract]   [Full Text] [Related]  

  • 10. EXPERIMENTAL studies of vaccination, allergy, and immunity in tuberculosis. VI. Comparative effects of BCG, H37Ra, Mycobacterium phlei and a wax-protein fraction of human tubercle bacilli.
    Am J Hyg; 1955 Nov; 62(3):270-82. PubMed ID: 13268417
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative study of the virulence and protective potency against tuberculous infection of vole bacillus, low-virulent human tubercle bacillus Imamura's strain, and BCG.
    TOSHIMA M
    Sci Rep Res Inst Tohoku Univ Med; 1952 Dec; 4(2):135-49. PubMed ID: 13064629
    [No Abstract]   [Full Text] [Related]  

  • 12. THE EFFICACY OF KILLED ANTITUBERCULOUS VACCINES IN RELATION TO THE MORPHOLOGICAL INTEGRITY OF THE SUSPENDED BACILLARY CELLS.
    PETRAGNANI G
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:77-80. PubMed ID: 14164139
    [No Abstract]   [Full Text] [Related]  

  • 13. B.C.G. AND vole bacillus vaccines in the prevention of tuberculosis in adolescents; first (progress) report to the Medical Research Council by their Tuberculosis Vaccines Clinical Trials Committee.
    Br Med J; 1956 Feb; 1(4964):413-27. PubMed ID: 13284343
    [No Abstract]   [Full Text] [Related]  

  • 14. TUBERCULOIMMUNITY INDUCED BY KILLED TUBERCLE BACILLI AND THEIR CONSTITUENTS.
    CROWLE AJ
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:27-34. PubMed ID: 14164134
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental study of BCG and urea-treated tubercle bacilli].
    AUFDERMAUR M; BRODHAGE H
    Schweiz Z Pathol Bakteriol; 1955; 18(6):1237-43. PubMed ID: 13337295
    [No Abstract]   [Full Text] [Related]  

  • 16. [Resistance induced by tuberculosis vaccination by killed Koch bacilli with (V.D.S.) or without addition of spreading factor; comparison with BCG].
    DEGLI ESPOSTI A
    Lotta Tuberc; 1955; 25(5-6):250-70. PubMed ID: 13252969
    [No Abstract]   [Full Text] [Related]  

  • 17. THE EFFECTS IN MICE OF INFECTION WITH GROUP IIIA UNCLASSIFIED MYCOBACTERIA AND BCG ON CHALLENGE INFECTION WITH M. TUBERCULOSIS.
    DUNBAR FP; CACCIATORE R; ARMSTRONG AL
    Am Rev Respir Dis; 1964 Feb; 89():280-3. PubMed ID: 14117691
    [No Abstract]   [Full Text] [Related]  

  • 18. Vole bacillus vaccination in guinea pigs: comparison of immunization produced by virulent and attenuated strains of vole bacillus.
    SMITH N
    Tubercle; 1962 Jun; 43():161-5. PubMed ID: 13914367
    [No Abstract]   [Full Text] [Related]  

  • 19. RESISTANCE TO EXPERIMENTAL TUBERCULOSIS STIMULATED BY FRACTIONS FROM ATTENUATED TUBERCLE BACILLI.
    RIBI E; LARSON CL; WICHT W; LIST R; GOODE G
    Proc Soc Exp Biol Med; 1965 Apr; 118():926-33. PubMed ID: 14277712
    [No Abstract]   [Full Text] [Related]  

  • 20. The persistence of resistance following the disappearance of hypersensitivity in guinea-pigs after vaccination with vole bacillus and BCG.
    WELLS AQ; WYLIE JA
    Br J Exp Pathol; 1952 Aug; 33(4):405-14. PubMed ID: 14954113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.